Related references
Note: Only part of the references are listed.IDH1 mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis
Yu Gu et al.
BLOOD (2021)
Functional Analysis of DNMT3A DNA Methyltransferase Mutations Reported in Patients with Acute Myeloid Leukemia
Daria A. Khrabrova et al.
BIOMOLECULES (2020)
Traditional Chinese Medicine Containing Arsenic Treated MDS Patients Effectively through Regulating Aberrant Hypomethylation
Qing-bing Zhou et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Structural basis for impairment of DNA methylation by the DNMT3A R882H mutation
Hiwot Anteneh et al.
NATURE COMMUNICATIONS (2020)
Expression and prognosis analysis of DNMT family in acute myeloid leukemia
Ting-Juan Zhang et al.
Aging-US (2020)
DNA methyltransferases in hematological malignancies
Nguyet-Minh Hoang et al.
JOURNAL OF GENETICS AND GENOMICS (2020)
The DNA methylation landscape of hematological malignancies: an update
Pedro Blecua et al.
MOLECULAR ONCOLOGY (2020)
Epigenetic Therapies for Cancer
Susan E. Bates
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effect of Qinghuang Powder Combined with Bupi Yishen Decoction in Treating Patients with Refractory Cytopenia with Multilineage Dysplasia through Regulating DNA Methylation
Zhou Qing-bing et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2019)
Epigenetic therapy in hematological cancers
Konstantinos Dimopoulos et al.
APMIS (2019)
Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners
Jonathan E. Sandoval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Quercetin modifies 5′CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells
Madhumitha Kedhari Sundaram et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL
Candace J. Poole et al.
EPIGENETICS & CHROMATIN (2019)
Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects
Faiz-ul Hassan et al.
FRONTIERS IN GENETICS (2019)
Synergistic Antioncogenic Activity of Azacitidine and Curcumin in Myeloid Leukemia Cell Lines and Patient Samples
Ivan Martin et al.
ANTICANCER RESEARCH (2019)
A Unique Epigenomic Landscape Defines Human Erythropoiesis
Vincent P. Schulz et al.
CELL REPORTS (2019)
The R882H DNMT3A hot spot mutation stabilizes the formation of large DNMT3A oligomers with low DNA methyltransferase activity
Tuong-Vi Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers
Ramona Bledea et al.
SCIENTIFIC REPORTS (2019)
Genome-Wide DNA Methylation Profiles of Phlegm-Dampness Constitution
Haiqiang Yao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts
Jinghan Wang et al.
EBIOMEDICINE (2018)
An overview of epigenetics in Chinese medicine researches
Hu Xue-qing et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2017)
Impact of TET2 deficiency on iron metabolism in erythroblasts
Kyoko Inokura et al.
EXPERIMENTAL HEMATOLOGY (2017)
A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome
A. D. Kelly et al.
LEUKEMIA (2017)
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers
Jacob L. Glass et al.
CANCER DISCOVERY (2017)
TET2 in Normal and Malignant Hematopoiesis
Robert L. Bowman et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Effects of bufalin on up-regulating methylation of Wilm's tumor 1 gene in human erythroid leukemic cells
Li-pei Wang et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2017)
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia
Rachel E. Rau et al.
BLOOD (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a
Staci L. Haney et al.
CELL REPORTS (2016)
Comparison of DNA methylation profiles in human fetal and adult red blood cell progenitors
Samuel Lessard et al.
GENOME MEDICINE (2015)
The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers
David A. Russler-Germain et al.
CANCER CELL (2014)
Berberine induces apoptosis in human multiple myeloma cell line U266 through hypomethylation of p53 promoter
Yanwei Qing et al.
CELL BIOLOGY INTERNATIONAL (2014)
Clinical development of demethylating agents in hematology
Shyamala C. Navada et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites
Amber Hogart et al.
GENOME RESEARCH (2012)
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
Cyril Quivoron et al.
CANCER CELL (2011)
Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation
Gabriella Ficz et al.
NATURE (2011)
Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice
Myunggon Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Share Paper
